Apremilast is effective in controlling the progression of adult vitiligo: A case series
Author:
Affiliation:
1. Department of DermatologyCUTIS Institute of Dermatology Srinagar Jammu and Kashmir India
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.12923
Reference10 articles.
1. Long‐term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for≥ 156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2);Crowley J.;Journal of the American Academy of Dermatology.,2017
2. Repigmentation of tenacious vitiligo on apremilast;Huff S. B.;Case Reports in Dermatological Medicine,2017
3. Controversial issues in vitiligo patients: A review of old and recent treatments;Lotti T.;Dermatologic Therapy,2018
4. Childhood vitiligo: Response to methylprednisolone oral minipulse therapy and topical fluticasone combination;Majid I.;Indian Journal of Dermatology.,2009
5. Apremilast: A phosphodiesterase 4 inhibitor for the treatment of psoriatic arthritis;Mease P. J.;Rheumatology and Therapy.,2014
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Utility of prostaglandin analogues and phosphodiesterase inhibitors as promising last resorts for the treatment of vitiligo: A systematic review, from mechanisms of action to mono‐, combination and comparative therapies;Journal of Cosmetic Dermatology;2024-08-19
2. Up-and-Coming Drugs for the Treatment of Vitiligo;ANN DERMATOL;2024
3. Apremilast versus betamethasone oral mini-pulse in the treatment of progressive non-segmental vitiligo: A randomised pilot trial;Indian Journal of Dermatology, Venereology and Leprology;2024-07-26
4. Implication of colloidal therapeutics in the treatment of vitiligo: Portray of signaling cascade, current drug-targets and preclinical and clinical evidences;Journal of Drug Delivery Science and Technology;2024-06
5. Research Progress in Small Molecules as Anti-vitiligo Agents;Current Medicinal Chemistry;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3